Paraskevi Giannakakou

Cornell University — United States

Medicine · Health Sciences

59h-index14.5kcitations364works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(158), Cancer Treatment and Pharmacology(74), Microtubule and mitosis dynamics(68), Cancer Genomics and Diagnostics(54), Radiopharmaceutical Chemistry and Applications(42)

Publications364 total

FOXJ1 mediates taxane resistance through regulation of microtubule dynamics
Nature Communications·2026Open Access
TMPO promotes cellular dissemination and metastasis in circulating tumor cells
2025Open Access
Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications
Physiological Reviews·2025
Comparative evaluation of Circulating Tumor Cell (CTC) enrichment strategies in lung and breast cancers
The Journal of Liquid Biopsy·2025Open Access
APOBEC3A-Induced DNA Damage Drives Polymerase θ Dependency and Synthetic Lethality in Cancer
2025Open Access
FOXJ1 mediates taxane resistance through regulation of microtubule dynamics
2025Open Access
Abstract 1645: Developing first-in-class AR-V7/AR-fl molecular glue degrader to revolutionize prostate cancer therapeutics
Cancer Research·2025
Abstract 3081: The multiciliated transcription factor FOXJ1 modulates microtubule dynamics and mediates taxane resistance in prostate cancer
Cancer Research·2025
Aging-dependent dysregulation of EXOSC2 is maintained in cancer as a dependency
2025Open Access
Advances in metastatic prostate cancer circulating tumor cell enrichment technologies and clinical studies
International review of cell and molecular biology·2024· 1 cited
Transferrin receptor-based circulating tumor cell enrichment provides a snapshot of the molecular landscape of solid tumors and correlates with clinical outcomes
2024· 1 citedOpen Access
Abstract 1231: First-in-class AR-V7/AR-fl small molecule molecular glue degrader for prostate cancer treatment
Cancer Research·2024· 1 cited
Abstract 1404: Blood-based transcriptomics provides novel insights into Sjögren's syndrome-associated lymphomagenesis
Cancer Research·2024
Abstract 2009: Novel clinically relevant CLIP-170 variants display an extended conformation microtubule-lattice bound conformation associated with taxane resistance
Cancer Research·2024
Abstract 6271: Novel insights into androgen receptor-variant 7 subnuclear localization and function in castration resistant prostate cancer
Cancer Research·2024
Abstract 1742: Cediranib reverses taxane resistance in CLIP-170S expressing gastric cancer
Cancer Research·2023· 1 cited
File S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer
2023Open Access
Data from Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes
2023Open Access
Figure S1 from Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer
2023Open Access
Supplementary Tables 1-4, Figures 1-4 from Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes
2023Open Access
page 1 of 19Next →

Frequent Co-authors

Tito Fojo(10), Aurora O’Brate(10), David M. Nanus(9), Giuseppe Galletti(7), Scott T. Tagawa(7), Daniel Escuín(5), Ernest Hamel(5), Ada Gjyrezi(5), Brian J. Kirby(5), Mikhail V. Blagosklonny(5), Dan L. Sackett(4), Maria Thadani‐Mulero(4), Marisa Carbonaro(4), K. C. Nicolaou(4), K. C. Nicolaou(3), Jun Zhou(3), Neil H. Bander(3), Erica D. Pratt(3), Emmanuel S. Antonarakis(3), Luigi Portella(3)